Yonezawa Hamari’s High Potency Drug Manufacture Facility’s Construction Started!

Hamari Group has started construction of a high potency drug substance manufacture facility at Yonezawa Hamari Chemicals, Ltd., Hamari’s main commercial production site. The facility will be operation in April 2019. Exposure management is Category 4 and the facility is equipped with reactors, a centrifugal separator, a filter dryer and a pin-milling machine. The facility can also support the production of injection-grade APIs.
Yonezawa Hamari, as an important constituent of the Hamari Group, will advance Hamari’s goal of achievement a comprehensive production system.
more details…